Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $80M
Founded date: 2020
Investors 4
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | MRL Ventur... | mrlv.com |
| - | Altitude L... | altitudels... |
| 16.06.2023 | Ono Ventur... | onoventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.06.2023 | Series A | $25M | UPMC Enter... |
| 26.10.2021 | Series A | $55M | - |
Mentions in press and media 11
| Date | Title | Description |
| 16.06.2023 | Ono Venture Investment Invests in Mozart Therapeutics. (Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for... | - |
| 07.06.2023 | Mozart Therapeutics lands $25M to develop therapies for autoimmune, inflammatory diseases | Mozart CEO Katie Fanning. (Mozart Photo) New funding: Seattle biotech company Mozart Therapeutics announced $25 million in new funding Wednesday to further its development of therapies for celiac and other autoimmune conditions. The therapy... |
| 07.06.2023 | Mozart Therapeutics Raises $25M in Expanded Series A Financing | Mozart Therapeutics, a Seattle, WA-based developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases, raised $25M in Series A extension. The round, which brought the total amount to $80M, saw participation fro... |
| 29.10.2021 | Funding news: Microsoft vets land cash for new sales data sharing startup, and more PNW deals | Groopit CEO Tammy Savage. (Groopit Photo) Here’s our latest rundown on recent startup investment news in the Pacific Northwest. — Seattle startup Groopit landed $2 million to help frontline sales employees share data with their extended tea... |
| 27.10.2021 | Coinbase looks across the pond for inspiration | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Coinbase may be the most well-known crypto exchange in the U.S., but there are many companies in ... |
| 27.10.2021 | Coinbase looks across the pond for inspiration | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Coinbase may be the most well-known crypto exchange in the U.S., but there are many companies in ... |
| 27.10.2021 | Mozart Therapeutics Closes $55M in Series A | SEATTLE, WA, Mozart Therapeutics has secured $55 million in Series A funding led by ARCH Venture Partners. >> Click here for more funding data on Mozart Therapeutics >> To export Mozart Therapeutics funding data to PDF and E... |
| 26.10.2021 | Founded last year, Mozart Therapeutics lands $55M to develop therapies for celiac and other diseases | Mozart Therapeutics CEO Katie Fanning. (Mozart Photo) A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac disease and other immune-related conditions, the company announced... |
| 26.10.2021 | Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases | - Advancing First-In-Class CD8 Treg Modulators to Restore Immune Balance SEATTLE, Oct. 26, 2021 /PRNewswire/ -- Mozart Therapeutics, Inc., a new biopharmaceutical company targeting a novel immune pathway to change the course of autoimmune a... |
| 26.10.2021 | Eli Lilly, Bayer, Merck join Mozart's chorus to the tune of $55M, as it launches into allegro phase | Mozart's resonance down the ages has gone beyond the musical sphere and into life sciences as a new biotech startup names itself after him 230 years following his death, bringing in backers from the likes of Eli Lilly, Merck, Bayer and mult... |
Show more